Global Chronic kidney disease drugs market outlook and forecast 2023

Chronic Kidney Disease Drugs Market Outlook And Segment Forecasts To 2023

www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019

According to Stratistics MRC, the Global Chronic Kidney Disease (CKD) Drugs market is expected to grow from $12.87 billion in 2016 to reach $16.13 billion by 2023 with a CAGR of 3.2%. Drivers that are shaping the global market include, growing incidences of chronic kidney diseases, rise in aged population, rising incidence of diabetes and obesity related disorders, significant unmet requirements and beneficial reimbursement policies. On the other hand, factors such as intense competition from biosimilars and growing preferences of generic drugs are creating a negative impact on the market growth.

Browse the report: http://www.orbisresearch.com/reports/index/chronic-kidney-disease-ckddrugs-global-market-outlook-2017-2023 By end user, the hospital segment is anticipated to dominate the market globally. North America leads the global market with a largest market share driven by huge acceptance of advanced technological products.

Some of the key players profiled in this market include Hoffmann-La Roche Ltd., GlaxoSmithKline plc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., AstraZeneca plc, Pfizer, Inc., Amgen Inc., Kissei Pharmaceutical Co., Ltd, AbbVie, Inc., Keryx Biopharmaceuticals, Inc., Allergan plc., FibroGen Inc and Johnson & Johnson.

End Users Covered: Specialty Clinics Hospitals Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/351975

Drug Classes Covered: Calcium channel blockers Antihypertensive Anemia Treatment Drugs Antihyperlipidemic Erythropoiesis-stimulating agents (ESAs) Swelling Treatment Drugs Beta blockers Diuretics Angiotensin-II receptor blockers ACE Inhibitors Other Drug Classes Regions Covered: North America US Canada Mexico www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019

Europe Germany France Italy UK Spain Rest of Europe Asia Pacific Japan China India Australia New Zealand Rest of Asia Pacific Rest of the World Middle East Brazil Argentina South Africa Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements.

List Of Tables: 1 Global Chronic Kidney Disease (CKD) Market Analysis, By Region 2 Global Chronic Kidney Disease (CKD) Market Analysis, By End User 3 Global Chronic Kidney Disease (CKD) Market Analysis, By Specialty Clinics 4 Global Chronic Kidney Disease (CKD) Market Analysis, By Hospitals

www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019

5 Global Chronic Kidney Disease (CKD) Market Analysis, By Drug Class 6 Global Chronic Kidney Disease (CKD) Market Analysis, By Calcium channel blockers 7 Global Chronic Kidney Disease (CKD) Market Analysis, By Antihypertensive 8 Global Chronic Kidney Disease (CKD) Market Analysis, By Anemia Treatment Drugs 9 Global Chronic Kidney Disease (CKD) Market Analysis, By Antihyperlipidemic 10 Global Chronic Kidney Disease (CKD) Market Analysis, By Erythropoiesis-stimulating agents (ESAs) 11 Global Chronic Kidney Disease (CKD) Market Analysis, By Swelling Treatment Drugs 12 Global Chronic Kidney Disease (CKD) Market Analysis, By Beta blockers 13 Global Chronic Kidney Disease (CKD) Market Analysis, By Diuretics 14 Global Chronic Kidney Disease (CKD) Market Analysis, By Angiotensin-II receptor blockers 15 Global Chronic Kidney Disease (CKD) Market Analysis, By ACE Inhibitors About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients.

We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information: Hector Costello Senior Manager – Client Engagements 4144N Central Expressway, Suite 600, Dallas, Texas – 75204, U.S.A. Phone No.: +1 (214) 884-6817; +9164101019 Email: sales@orbisresearch.com

www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019